Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy

Developmental Medicine and Child Neurology

Volumn 44, Issue 12, 2002, Pages 820-827

  Reddihough, Dinah S ^c   King, Jane A ^a   Coleman, Grahame J ^b   Fosang, Adrienne ^c   McCoy, Anne T ^d   Thomason, Pamela ^c   Graham, H Kerr ^c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FUNCTIONAL ASSESSMENT; GONIOMETRY; HUMAN; INCONTINENCE; INFANT; INJECTION PAIN; INJECTION SITE; JOINT FUNCTION; LEG; LEG MOVEMENT; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE WEAKNESS; PHYSIOTHERAPY; PILOT STUDY; PLASTER CAST; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; SPASTIC PARESIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036889782     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162201002997     Document Type: Article

References (46)

1. Ade-Hall RA, Moore AP. (2002) Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. The Cochrane Library. Issue 3. Oxford: Update Software.
2. Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G, Graham HK. (2000) Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Developmental Medicine & Child Neurology 42: 116-21.
3. Bohannon RW, Smith MB. (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 67: 206-7.
4. Boyce W, Gowland C, Rosenbaum P, Lane M, Plews N, Goldsmith C, Russell D, Wright V, Potter S, Harding D. (1995) The Gross Motor Performance Measure: validity and responsiveness of a measure of quality of movement. Physical Therapy 81: 603-13.
5. Boyd RN, Graham HK. (1997) Botulinum toxin A in the management of children with cerebral palsy: indications and outcomes. European Journal of Neurology 4 (Suppl. 2): 15-22.
6. Boyd RN, Pliatsios V, Starr R, Nattrass G, Graham HK. (2000) Biomechanical transformation of the gastrosoleus muscle by injection of Botulinum toxin A in ambulant children with cerebral palsy. Developmental Medicine & Child Neurology 42: 32-41.
7. Boyd RN, Dobson F, Parrott J, Love S, Oates J, Larson A, Burchell G, Chondros P, Carlin J, Nattrass G, Graham HK. (2001a) The effect of Botulinum toxin A and a variable hip abduction orthosis on gross motor function - a randomised controlled trial. European Journal of Neurology 8: 109-19.
8. Boyd RN, Hays RM. (2001b) Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. European Journal of Neurology 8: 1-20.
9. Burke D. (1988) Spasticity as an adaptation to pyramidal tract injury. Advances in Neurology 47: 401-23.
10. Butler C, Campbell S. (2000) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Developmental Medicine & Child Neurology 42: 634-45.
11. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, Garcia-Ramirez J, Mino-Arango E. (1994) Botulinum Toxin A in management of cerebral palsy. Pediatric Neurology 10: 284-8.
12. Carr JH, Shepherd RB, Ada L. (1995). Spasticity: research findings and implications for intervention. Physiotherapy 81: 421-9.
13. Catanese A, Coleman GJ, King JA, Reddihough DS. (1995) Evaluation of an early childhood program based on principles of Conductive Education: The Yooralla Project. Journal of Paediatrics and Child Health 31: 418-22.
14. Coleman GJ, King JA, Reddihough DS. (1995) A pilot evaluation of conductive education-based intervention for children with cerebral palsy: the Tongala Project. Journal of Paediatrics and Child Health 31: 412-17.
15. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. (1997) Botulinum Toxin A in the hemiplegic upper limb: a double-blind trial. Developmental Medicine & Child Neurology 39: 185-93.
16. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. (1998) Botulinum Toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective study. Journal of Pediatric Orthopaedics 18: 307-11.
17. Cosgrove AP, Corry IS, Graham HK. (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medicine & Child Neurology 36: 386-96.
18. Damiano DL, Abel MF. (1998) Functional outcomes of strength training in spastic cerebral palsy. Archives of Physical Medicine & Rehabilitation 79: 119-25.
19. Desloovere K, Molenaers G, Jonkers I, De Cat J, De Borre L, Nijs J, Eyssen M, De Cock P. (2001) A randomised study of combined botulinum toxin A and casting in the ambulant child with cerebral palsy using objective outcome measures. European Journal of Neurology 8: 75-87.
20. Eames NWA, Baker R, Hill N, Graham HK, Taylor T, Cosgrove A. (1999) The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Developmental Medicine & Child Neurology 41: 226-32.
21. Fehlings D, Rang M, Glazier J, Steele C. (2000) An evaluation of botulinum-A toxin injections to improve upper limb function in children with hemiplegic cerebral palsy. Journal of Pediatrics 137: 331-7.
22. Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. (1999) Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. Journal of Paediatrics and Child Health 35: 71-7.
23. Giuliani CA. (1991) Dorsal rhizotomy for children with cerebral palsy: support for concepts of motor control. Physical Therapy 71: 248-59.
24. Graham HK, Aoki KR, Autti-Ramo I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garcia RP, Wissel J. (2000) Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture 11: 67-79.
25. Katz RT, Rymer WZ. (1989) Spastic hypertonia: mechanisms and measurement. Archives of Physical Medicine and Rehabilitation 70: 144-55.
26. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. (1993) Management of cerebral palsy with botulinum-A toxin: preliminary investigations. Journal of Pediatric Orthopaedics 13: 489-95.
27. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. (1994) Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. Journal of Pediatric Orthopaedics 14: 299-303.
28. Koman LA, Mooney JF, Paterson Smith B, Walker F, Leon J, and the Botox Study Group. (2000) Botulinum toxin type a neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. Journal of Pediatric Orthopaedics 20: 108-15.
29. Maloney F, Mirrett P, Brooks C, Johannes K. (1978) Use of the Goal Attainment Scale in the treatment and ongoing evaluation of neurologically handicapped children. American Journal of Occupational Therapy 32: 505-10.
30. McDowell BC, Hewitt V, Nurse A, Weston T, Baker R. (2000) The variability of goniometric measurements in ambulatory children with spastic cerebral palsy. Gait and Posture 12: 114-21.
31. McLaughlin JF, Bjornson KF, Astley SJ, Graubert C, Hays RM, Roberts TS, Price R, Temkin N. (1998) Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Developmental Medicine & Child Neurology 40: 220-32.
32. Molenaers G, Desloovere K, Jonkers I, Glorieux F, De Cock P. (1999a) The effect of multilevel botulinum toxin type A treatment combined with short leg casting and orthotic management on the gait of CP children. Gait and Posture 10: 74. (Abstract).
33. Molenaers G, Desloovere K, Eyssen M, De Cat J, Jonkers I, De Cock P. (1999b) Botulinum toxin type A treatment of cerebral palsy: an integrated approach. European Journal of Neurology 6 (Suppl. 4): S51-7.
34. Palisano RJ, Rosenbaum PL, Walters SD, Russell D, Wood E, Galuppi B. (1997) Development and reliability of a system to classify gross motor function in cerebral palsy. Developmental Medicine & Child Neurology 39: 214-23.
35. Pierson SH. (1997) Outcome measures in spasticity management. Muscle and Nerve 6 (Suppl.): S36-60.
36. Richards CL, Malouin F. (1992) Spasticity control in the therapy of cerebral palsy. Medicine and Sports Science 36: 217-24.
37. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. (1989) The Gross Motor Function Measure: a means to evaluate the effects of physical therapy. Developmental Medicine & Child Neurology 31: 341-52.
38. Sheean GL. (2001) Botulinum treatment of spasticity: why is it so difficult to show a functional benefit. Current Opinion in Neurology 14: 771-6.
39. Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD. (1997) A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Developmental Medicine & Child Neurology 39: 178-84.
40. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. (1999) Double-blind study of botulinum toxin type A injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 10: 1-9.
41. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. (2000) Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Archives of Disease in Childhood 83: 481-7.
42. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. (2000) Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 46: 603-12.
43. Vulpe SG. (1982) Vulpe Assessment Battery. Toronto: National Institute on Mental Retardation.
44. Wong V. (1998) Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatric Neurology 18: 124-31.
45. Wright FV, Shell E, Drake JM, Wedge JH, Naumann S. (1998) Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Developmental Medicine & Child Neurology 40: 239-47.
46. Zelnik N, Giladi N, Goikhman I, Keren G, Moris R, Honigman S. (1997) The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy - a pilot study. Israel Journal of Medical Sciences 33: 129-33.